CBNK vs. AMRX
CBNK (Capital Bancorp, Inc.) and AMRX (Amneal Pharmaceuticals, Inc.) are both stocks. CBNK operates in Banks - Regional (Financial Services), while AMRX operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 5 years, CBNK returned 6.65%/yr vs 18.72%/yr for AMRX. At a 0.23 correlation, their price movements are largely independent.
Performance
CBNK vs. AMRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CBNK achieves a 12.59% return, which is significantly higher than AMRX's 2.18% return.
CBNK
- 1D
- -2.48%
- 1M
- 2.60%
- YTD
- 12.59%
- 6M
- 10.63%
- 1Y
- 0.77%
- 3Y*
- 23.77%
- 5Y*
- 6.65%
- 10Y*
- —
AMRX
- 1D
- 1.78%
- 1M
- -1.79%
- YTD
- 2.18%
- 6M
- 5.71%
- 1Y
- 72.82%
- 3Y*
- 71.55%
- 5Y*
- 18.72%
- 10Y*
- -9.35%
CBNK vs. AMRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
CBNK Capital Bancorp, Inc. | 12.59% | 0.27% | 19.66% | 4.31% | -9.31% | 88.84% | -6.45% | 30.50% | -10.86% |
AMRX Amneal Pharmaceuticals, Inc. | 2.18% | 59.09% | 30.48% | 205.03% | -58.46% | 4.81% | -5.19% | -64.38% | -38.70% |
Correlation
The correlation between CBNK and AMRX is 0.35, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.35 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.31 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Sep 27, 2018 | 0.23 |
The correlation between CBNK and AMRX shifts across timeframes, from 0.23 (all time) to 0.35 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
CBNK:
$517.56M
AMRX:
$4.24B
CBNK:
$3.32
AMRX:
$0.38
CBNK:
9.48
AMRX:
34.22
CBNK:
1.11
AMRX:
1.19
CBNK:
2.12
AMRX:
1.37
CBNK:
1.27
AMRX:
5.51
CBNK:
$247.42M
AMRX:
$3.05B
CBNK:
$167.22M
AMRX:
$1.18B
CBNK:
$59.62M
AMRX:
$626.02M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CBNK vs. AMRX — Risk / Return Rank
CBNK
AMRX
CBNK vs. AMRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Capital Bancorp, Inc. (CBNK) and Amneal Pharmaceuticals, Inc. (AMRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CBNK | AMRX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.03 | 2.32 | -2.29 |
Sortino ratioReturn per unit of downside risk | 0.22 | 2.99 | -2.77 |
Omega ratioGain probability vs. loss probability | 1.03 | 1.37 | -0.34 |
Calmar ratioReturn relative to maximum drawdown | 0.03 | 3.29 | -3.26 |
Martin ratioReturn relative to average drawdown | 0.06 | 8.19 | -8.14 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CBNK | AMRX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.03 | 2.32 | -2.29 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.24 | 0.37 | -0.13 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | -0.14 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.29 | 0.10 | +0.19 |
Drawdowns
CBNK vs. AMRX - Drawdown Comparison
The maximum CBNK drawdown since its inception was -53.68%, smaller than the maximum AMRX drawdown of -97.52%. Use the drawdown chart below to compare losses from any high point for CBNK and AMRX.
Loading charts...
Drawdown Indicators
| CBNK | AMRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -53.68% | -97.52% | +43.84% |
Max Drawdown (1Y)Largest decline over 1 year | -24.81% | -22.25% | -2.56% |
Max Drawdown (3Y)Largest decline over 3 years | -24.81% | -26.80% | +1.99% |
Max Drawdown (5Y)Largest decline over 5 years | -43.34% | -78.90% | +35.56% |
Max Drawdown (10Y)Largest decline over 10 years | — | -96.28% | — |
Current DrawdownCurrent decline from peak | -10.39% | -74.91% | +64.52% |
Average DrawdownAverage peak-to-trough decline | -15.14% | -54.31% | +39.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.71% | 8.92% | +4.79% |
Volatility
CBNK vs. AMRX - Volatility Comparison
The current volatility for Capital Bancorp, Inc. (CBNK) is 6.13%, while Amneal Pharmaceuticals, Inc. (AMRX) has a volatility of 9.50%. This indicates that CBNK experiences smaller price fluctuations and is considered to be less risky than AMRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CBNK | AMRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.13% | 9.50% | -3.37% |
Volatility (6M)Calculated over the trailing 6-month period | 17.33% | 22.37% | -5.04% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.67% | 31.62% | -5.95% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.32% | 50.91% | -22.59% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.80% | 65.26% | -18.46% |
Dividends
CBNK vs. AMRX - Dividend Comparison
CBNK's dividend yield for the trailing twelve months is around 1.52%, while AMRX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
AMRX Amneal Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CBNK Capital Bancorp, Inc. | 1.52% | 1.56% | 1.26% | 1.16% | 0.93% | 0.38% |
Financials
CBNK vs. AMRX - Financials Comparison
This section allows you to compare key financial metrics between Capital Bancorp, Inc. and Amneal Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CBNK vs. AMRX - Profitability Comparison
CBNK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Capital Bancorp, Inc. reported a gross profit of 0.00 and revenue of 19.09M. Therefore, the gross margin over that period was 0.0%.
AMRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Amneal Pharmaceuticals, Inc. reported a gross profit of 320.11M and revenue of 722.52M. Therefore, the gross margin over that period was 44.3%.
CBNK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Capital Bancorp, Inc. reported an operating income of 0.00 and revenue of 19.09M, resulting in an operating margin of 0.0%.
AMRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Amneal Pharmaceuticals, Inc. reported an operating income of 133.54M and revenue of 722.52M, resulting in an operating margin of 18.5%.
CBNK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Capital Bancorp, Inc. reported a net income of 12.02M and revenue of 19.09M, resulting in a net margin of 63.0%.
AMRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Amneal Pharmaceuticals, Inc. reported a net income of 62.50M and revenue of 722.52M, resulting in a net margin of 8.7%.
Frequently Asked Questions
CBNK and AMRX have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AMRX has higher volatility (9.50%) compared to CBNK (6.13%). In terms of maximum drawdown, CBNK dropped -53.68% vs AMRX's -97.52%.
AMRX currently has the higher Sharpe Ratio (2.32 vs 0.03), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CBNK and AMRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer